A 52-year-old woman with cirrhosis (Child-Pugh Class C) and ascites is admitted with spontaneous bacterial peritonitis (SBP). She is febrile (38.8°C), hypotensive (SBP 88 mmHg), tachycardic (HR 112/min), and tachypneic (RR 22/min). Ascitic fluid analysis shows WBC 650/μL (neutrophils 85%), protein 1.2 g/dL, glucose 45 mg/dL. Serum creatinine has risen from baseline 1.0 to 2.8 mg/dL in 48 hours. After 2 liters of crystalloid over 6 hours, her blood pressure remains 92/56 mmHg. What is the most appropriate next step in management?

Explanation

## Septic Shock in Cirrhosis: SBP with Organ Dysfunction **Key Point:** This patient has septic shock (hypotension despite fluids, elevated lactate risk, acute kidney injury) secondary to SBP. Cirrhotic patients require a specialized approach combining vasopressor support, antibiotics, and albumin to prevent hepatorenal syndrome (HRS). ## Clinical Recognition | Finding | Interpretation | |---------|----------------| | Ascitic WBC >250/μL + neutrophils >50% | SBP confirmed | | Glucose 45 mg/dL in ascites | Marker of severe infection (bacterial consumption) | | Creatinine rise 1.0 → 2.8 in 48 hrs | Acute kidney injury (likely HRS-AKI Type 1) | | Persistent hypotension after 2 L fluids | Septic shock; vasopressor threshold met | | Low ascitic protein (1.2 g/dL) | High risk for SBP (spontaneous, not secondary) | **High-Yield:** In cirrhosis, SBP is a medical emergency with 30-day mortality ~20% if treated, ~80% if untreated. The combination of infection + renal dysfunction defines hepatorenal syndrome. ## Management Algorithm ```mermaid flowchart TD A[SBP diagnosed: ascitic WBC >250 + PMN >50%]:::outcome --> B[Start ceftriaxone 1g IV Q12H]:::action B --> C[Fluid challenge: 30 mL/kg crystalloid]:::action C --> D{BP ≥90 systolic?}:::decision D -->|Yes| E[Continue antibiotics + monitor]:::action D -->|No| F[Start noradrenaline: target MAP ≥65]:::action F --> G[Add albumin: 1.5 g/kg day 1, then 1 g/kg days 2-3]:::action G --> H[Monitor creatinine, urine output, lactate]:::action H --> I{Creatinine doubles or Cr >2.5?}:::decision I -->|Yes| J[Diagnose HRS-AKI; consider terlipressin + octreotide]:::action I -->|No| K[Continue current regimen; reassess daily]:::action ``` ## Albumin in SBP + Septic Shock **Clinical Pearl:** Albumin is NOT a volume expander in cirrhosis; it is a **renoprotective agent** that: - Expands effective circulating volume (splanchnic vasodilation in cirrhosis reduces effective intravascular volume despite ascites) - Reduces HRS incidence by ~50% when combined with vasopressors - Dosing: **1.5 g/kg on day 1** (e.g., 105 g for 70 kg patient), then **1 g/kg on days 2–3** This is unique to SBP in cirrhosis and is supported by multiple RCTs and guidelines (AASLD, EASL). ## Vasopressor Choice: Noradrenaline vs. Terlipressin | Agent | Use in SBP | Rationale | |-------|-----------|----------| | **Noradrenaline** | First-line for septic shock | Increases MAP, maintains renal perfusion; standard sepsis protocol | | **Terlipressin** | Adjunct if HRS develops despite noradrenaline | Splanchnic vasoconstrictor; used for HRS-AKI, not initial septic shock | **Warning:** Terlipressin is NOT superior to noradrenaline in initial septic shock management. It is reserved for hepatorenal syndrome (HRS-AKI or HRS-NAKI) when renal function continues to deteriorate despite noradrenaline + albumin. ## Monitoring for Hepatorenal Syndrome HRS-AKI is diagnosed if: - Serum creatinine doubles to >2.5 mg/dL within 2 weeks, OR - Urine output <0.5 mL/kg/hr despite fluids and vasopressors, OR - Oliguria develops At that point, add **terlipressin 0.5–1 mg IV Q4–6H** + **octreotide 100 μg SC TID** + continue noradrenaline. **Mnemonic:** **CRASH-C** (Ceftriaxone, Resuscitate fluids, Albumin, Septic shock protocol, Hepatorenal watch, Creatinine monitoring). [cite:AASLD Hepatic Encephalopathy & SBP Guidelines 2018, Harrison 21e Ch 297, Robbins 10e Ch 20]